FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069129 [Registered on: 18/06/2024] Trial Registered Prospectively
Last Modified On: 11/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparision of prophylactic infusion of Phenylephrine versus Norepinephrine for the prevention of post spinal hypotension in parturients undergoing elective caesaeran section-A double blinded,randomised controlled trial 
Scientific Title of Study   Comparision of prophylactic infusion of Phenylephrine versus Norepinephrine for the prevention of post spinal hypotension in parturients undergoing elective caesaeran section-A double blinded, non inferiority, randomised controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrAnil Kumar Ganeshnavar 
Designation  Professor 
Affiliation  S.Nijalingappa Medical College 
Address  Department of Anaesthesiology,S.N.M.C and HSK Hospital,Navanagar,Bagalkot Bagalkot Karnataka

Bagalkot
KARNATAKA
587102
India 
Phone  9964526598  
Fax    
Email  anilganesh22@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrAnil Kumar Ganeshnavar 
Designation  Professor 
Affiliation  S.Nijalingappa Medical College 
Address  S.Nijalingappa Medical College Department of Anaesthesiology Bagalkot Karnataka

Bagalkot
KARNATAKA
587102
India 
Phone  9964526598  
Fax    
Email  anilganesh22@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rachana R 
Designation  Junior Resident 
Affiliation  S.Nijalingappa Medical College 
Address  Department of Anaesthesiology,S.N.M.C and HSK Hospital,Navanagar Bagalkot Karnataka

Bagalkot
KARNATAKA
587102
India 
Phone  9964526598  
Fax    
Email  rachanaranganath96@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesia,S.Nijalingappa Medical College and HSK Hospital,Bagalkot -587102 
S.Nijalingappa Medical College 
 
Primary Sponsor  
Name  Department of Anaesthesia 
Address  S.Nijalingappa Medical College and HSK Hospital,Bagalkot 587102. Karnataka,India  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrAnilkumar Ganeshnavar  Department of Anaesthesia,HSK Hospital and Research Centre   S.Nijalingappa Medical College and HSK Hospital,Navanagar,Bagalkot-587102,Karnataka,India
Bagalkot
KARNATAKA 
9964526598

anilganesh22@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
S.Nijalingappa Medical College Institutional Ethics Committee and Research   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  , (1) ICD-10 Condition: O748||Other complications of anesthesiaduring labor and delivery,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Parturients undergoing Elective Caesarean section  Patients will be fasted overnight and will given IV metoclopramide 10 mg and Pantoprazole 40 mg iv. On arrival to the operating room , electrocardiogram, non-invasive blood pressure (BP), and SpO2 monitors will be attached. Baseline heart rate (HR) and BP will be noted with the patient in supine position with left lateral tilt. An 18G IV cannula will be placed and coloading will be achieved using 500 mL of lactated Ringer solution. Another wide-bore cannula will be placed in the in the contralateral arm. Participants will be randomly allocated into 2 groups using computer generated random number tables. Group B participants will receive Norepinephrine 5mcg/min iv at 15ml/hr. Subarachnoid block (SAB) will be administered by an experienced anaesthesiologist with 12.5 mg 0.5% bupivacaine heavy in the L3-L4 interspace using a 25 G Quincke needle with the patient in the sitting position. After the block, patients will be made supine with left lateral tilt, and vasopressor infusion will be started at 15 mL/ hr according to the group allocation and observed for 60 minutes. 
Intervention  Paturients undergoing Elective caesarean section   Patients will be fasted overnight and will given IV metoclopramide 10 mg and Pantoprazole 40 mg iv.On arrival to the operating room , electrocardiogram, non-invasive blood pressure (BP), and SpO2 monitors will be attached. Baseline heart rate (HR) and BP will be noted with the patient in supine position with left lateral tilt. An 18G IV cannula will be placed and coloading will be achieved using 500 mL of lactated Ringer solution. Another wide-bore cannula will be placed in the in the contralateral arm.Participants will be randomly allocated into 2 groups using computer generated random number tables.Group A participants will receive Phenylephrine 50mcg/min iv at 15ml/hr. Subarachnoid block (SAB) will be administered by an experienced anaesthesiologist with 12.5 mg of bupivacaine heavy 0.5% in the L3-L4 interspace using a 25 G Quincke needle with the patient in the sitting position. After the block, patients will be made supine with left lateral tilt, and vasopressor iv infusion will be started at 15 mL/ hr according to the group allocation and observed for 60 minutes  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  American Society of Anaesthesiologist grade
Non labouring,normotensive parturients
Term singleton pregnancy
Posted for Elective caesarean section under Spinal anaesthesia
 
 
ExclusionCriteria 
Details  Known fetal abnormality,
Pre existing or pregnancy-induced hypertension,
Known cardiovascular or cerebrovascular disease,
Allergy or hypersensitivity to study drugs
Thrombocytopenia, coagulopathy, or any medical contraindication to spinal
anaesthesia
Weight-50-100kg
Height-140 or 180cm
Patients who refused to give consent 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To measure proportion of hypotension between 2 groups  1 hour 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary objectives - incidence of maternal bradycardia, nausea and vomiting, reactive hypertension, requirement of rescue boluses of vasopressor and atropine between the 2 groups.  1 hour 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   24/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Spinal anaesthesia is the technique of choice for elective caesarean delivery; however this technique results in hypotension in the vast majority of women if not actively prevented. The consequences of spinal hypotension in this setting are proportional to the severity and include nausea and vomiting, decrease in uteroplacental blood flow, fetal acidosis, and rarely, cardiovascular collapse. Without prophylactic Vasopressors, post spinal hypotension affects neatly 60% of women during caesarean delivery; thus using vasopressors have been highly recommended for routine prevention of post spinal hypotension during caesarean delivery. Phenylephrine is a potent α -adrenergic receptor agonist as emerged as the vasopressor of choice for management of post spinal hypotension. It’s use is often associated with a dose related reflexive slowing of maternal heart rate(HR) and a corresponding decrease in cardiac output(CO).Although the clinical significance of these decreases in HR and CO in healthy patients with unstressed fetuses is unknown, concern has been expressed that there may be potential for harm in the presence of a compromised fetus. Hence the use of norepinephrine which is characterized by α -adrenergic agonistic activity in addition to a weak β -adrenergic agonistic activity, is recommended as vasopressor with minimal cardiac depressant effect to prevent maternal hypotension. These pharmacologic properties would make norepinephrine an attractive alternative to phenylephrine and ephedrine in obstetric anaesthesia. We postulated that norepinephrine might therefore be an effective vasopressor for maintaining blood pressure during spinal anaesthesia with less tendency to decrease Heart rate and Cardiac output. 
Close